These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 2646222

  • 1. 6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Present DH.
    Gastroenterol Clin North Am; 1989 Mar; 18(1):57-71. PubMed ID: 2646222
    [Abstract] [Full Text] [Related]

  • 2. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM.
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [Abstract] [Full Text] [Related]

  • 3. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA.
    Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
    [Abstract] [Full Text] [Related]

  • 4. Immunosuppressive therapy of inflammatory bowel disease: a historical perspective.
    Korelitz BI.
    Gastroenterologist; 1995 Jun; 3(2):141-52. PubMed ID: 7640945
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J, Grancher K, Mandel F, Daum F.
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [Abstract] [Full Text] [Related]

  • 6. The drug therapy of ulcerative colitis and of Crohn's disease.
    Tumen HJ.
    Semin Drug Treat; 1974 Jan; 3(4):339-49. PubMed ID: 4150770
    [No Abstract] [Full Text] [Related]

  • 7. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease.
    Markowitz JF.
    Rev Gastroenterol Disord; 2003 Jan; 3 Suppl 1():S23-9. PubMed ID: 12684586
    [Abstract] [Full Text] [Related]

  • 8. Immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Hibi T, Iwao Y, Yajima T, Inoue N, Ueno Y, Takaishi H, Watanabe M, Ishii H.
    J Gastroenterol; 1995 Nov; 30 Suppl 8():121-3. PubMed ID: 8563872
    [Abstract] [Full Text] [Related]

  • 9. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X, Serre-Debeauvais F, Phelip JM, Faucheron JL, Hardy G, Chartier A, Helluwaert F, Bessard G, Bonaz B.
    Aliment Pharmacol Ther; 2005 Apr 01; 21(7):829-39. PubMed ID: 15801918
    [Abstract] [Full Text] [Related]

  • 10. Azathioprine, 6-mercaptopurine and thiopurine S-methyltransferase.
    Roberts-Thomson IC, Butler WJ.
    J Gastroenterol Hepatol; 2005 Jun 01; 20(6):955. PubMed ID: 15946151
    [No Abstract] [Full Text] [Related]

  • 11. [Immunosuppressive therapy of ulcerative colitis and Crohn's disease].
    Reitzig P, Apostoloff E, Lisewski G, Spranger GD.
    Dtsch Gesundheitsw; 1973 Jun 01; 28(5):238-40. PubMed ID: 4722981
    [No Abstract] [Full Text] [Related]

  • 12. Is thiopurine therapy in ulcerative colitis as effective as in Crohn's disease?
    Ghosh S, Chaudhary R, Carpani M, Playford RJ.
    Gut; 2006 Jan 01; 55(1):6-8. PubMed ID: 16344570
    [Abstract] [Full Text] [Related]

  • 13. [Immunodepressants in the treatment of Crohn's disease and non-specific ulcerative colitis].
    Radbil' OS.
    Klin Med (Mosk); 1976 Mar 01; 54(3):8-14. PubMed ID: 787661
    [No Abstract] [Full Text] [Related]

  • 14. Medical management of patients with difficult-to-treat inflammatory bowel disease.
    van Hogezand RA.
    Neth J Med; 1994 Aug 01; 45(2):55-9. PubMed ID: 7936006
    [Abstract] [Full Text] [Related]

  • 15. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun 01; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 16. Infliximab and/or azathioprine in the treatment of Crohn's disease-like complications after IPAA.
    Haveran LA, Sehgal R, Poritz LS, McKenna KJ, Stewart DB, Koltun WA.
    Dis Colon Rectum; 2011 Jan 01; 54(1):15-20. PubMed ID: 21160308
    [Abstract] [Full Text] [Related]

  • 17. [Immunosuppressive therapy of inflammatory diseases of the large intestine].
    Rumiantsev VG, Rogozina VA, Osina VA.
    Eksp Klin Gastroenterol; 2004 Jan 01; (6):89-98, 165. PubMed ID: 16259448
    [Abstract] [Full Text] [Related]

  • 18. Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories?
    Sands BE.
    Gut; 2006 Apr 01; 55(4):437-41. PubMed ID: 16531519
    [Abstract] [Full Text] [Related]

  • 19. Oral tacrolimus treatment of severe colitis in children.
    Bousvaros A, Kirschner BS, Werlin SL, Parker-Hartigan L, Daum F, Freeman KB, Balint JP, Day AS, Griffiths AM, Zurakowski D, Ferry GD, Leichtner AM.
    J Pediatr; 2000 Dec 01; 137(6):794-9. PubMed ID: 11113835
    [Abstract] [Full Text] [Related]

  • 20. [Role of thiopurine agents in ulcerative colitis].
    Chaparro M, Gisbert JP.
    Gastroenterol Hepatol; 2011 Dec 01; 34 Suppl 3():30-5. PubMed ID: 25443224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.